Literature DB >> 12888909

Inhibition of NF-kappaB pathway in grape seed extract-induced apoptotic death of human prostate carcinoma DU145 cells.

Sivanandhan Dhanalakshmi1, Rajesh Agarwal, Chapla Agarwal.   

Abstract

The alarmingly high rate of prostate cancer (PCA) mortality as well as the limited success in the treatment of advanced PCA suggest that additional approaches are needed to control PCA growth and its metastatic potential. A constitutive activation of NF-kappaB family of transcription factors is known to play a major role in chemotherapy resistance in advanced PCA. In recent studies we showed that grape seed extract (GSE) inhibits advanced human PCA growth and induces apoptosis in cell culture and in nude mice. Accordingly, here we assessed the effect of GSE on constitutive and TNFalpha-induced NF-kappaB DNA binding activity and apoptotic death in advanced human prostate carcinoma DU145 cells. Constitutive and TNFalpha-induced NF-kappaB DNA binding activity was inhibited by GSE at doses > or =50 microg/ml and treatments for > or =12 h. This was accompanied by inhibition of IkappaBalpha phosphorylation and IKKalpha kinase activity. A strong induction of apoptosis (P<0.01) was also observed following GSE treatment, while a combination with TNFalpha strongly potentiated apoptosis induction. Our results indicate the potential of developing GSE as an effective cancer therapeutic agent, both alone and in combination with TNFalpha-based chemotherapy of advanced human prostate carcinoma that might prove to be a more effective and less toxic alternative in clinical therapy of PCA.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12888909

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

Review 1.  The strategies to control prostate cancer by chemoprevention approaches.

Authors:  Harold Ting; Gagan Deep; Chapla Agarwal; Rajesh Agarwal
Journal:  Mutat Res       Date:  2014-01-02       Impact factor: 2.433

2.  Differential effect of grape seed extract and its active constituent procyanidin B2 3,3″-di-O-gallate against prostate cancer stem cells.

Authors:  Alpna Tyagi; Sushil Kumar; Komal Raina; Michael F Wempe; Paul D Maroni; Rajesh Agarwal; Chapla Agarwal
Journal:  Mol Carcinog       Date:  2019-03-03       Impact factor: 4.784

3.  Procyanidin B2 3,3(″)-di-O-gallate, a biologically active constituent of grape seed extract, induces apoptosis in human prostate cancer cells via targeting NF-κB, Stat3, and AP1 transcription factors.

Authors:  Alpna Tyagi; Komal Raina; Suraj Prakash Shrestha; Bettina Miller; John A Thompson; Michael F Wempe; Rajesh Agarwal; Chapla Agarwal
Journal:  Nutr Cancer       Date:  2013-11-05       Impact factor: 2.900

4.  Grape seed extract inhibits VEGF expression via reducing HIF-1alpha protein expression.

Authors:  Jianming Lu; Keqiang Zhang; Shiuan Chen; Wei Wen
Journal:  Carcinogenesis       Date:  2009-01-08       Impact factor: 4.944

5.  Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway.

Authors:  Wei Wen; Jianming Lu; Keqiang Zhang; Shiuan Chen
Journal:  Cancer Prev Res (Phila)       Date:  2008-12

Review 6.  Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products.

Authors:  Manjinder Kaur; Chapla Agarwal; Rajesh Agarwal
Journal:  J Nutr       Date:  2009-07-29       Impact factor: 4.798

7.  Induction of apoptosis in human leukemia cells by grape seed extract occurs via activation of c-Jun NH2-terminal kinase.

Authors:  Ning Gao; Amit Budhraja; Senping Cheng; Hua Yao; Zhuo Zhang; Xianglin Shi
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

Review 8.  Radiation-Induced Heart Diseases: Protective Effects of Natural Products.

Authors:  Ahmed Eleojo Musa; Dheyauldeen Shabeeb
Journal:  Medicina (Kaunas)       Date:  2019-05-09       Impact factor: 2.430

Review 9.  Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.

Authors:  Bharti Jaiswal; Akanksha Agarwal; Ashish Gupta
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-17       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.